by Site Dev | Oct 20, 2021
Lung Clinical Trials Contact Us BMS CA 209-153 Stage 4 NSCLC after progression for Stage 4 disease treatment (had multiple lines of metastatic treatment) Opened 7/30/2014 with our site enrolling 25 patients. Opdivo FDA approval of this drug in this setting for this...
